Efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma: Protocol for a randomized controlled clinical trial

Efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma: Protocol for a randomized controlled clinical trial

Background: Immune checkpoint inhibitor-induced immune-mediated hepatitis (ICI-IMH) in patients with hepatocellular carcinoma (HCC) has been established to increase the risk of liver failure (LF). Given the accumulating evidence supporting the efficacy of artificial liver support systems (ALSS) in m...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiumin Luo, Yeqiong Zhang, Zhipeng Li, Jia Chen, Zhexuan Deng, Jiadi Lai, Xiyao Chen, Chan Xie, Liang Peng, Ying Liu, Wenxiong Xu
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Heliyon
Subjects:
Hepatocellular carcinoma
Immune checkpoint inhibitors
Liver failure
Artificial liver support system
Double plasma molecular adsorption system
Plasma exchange
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024151262
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024151262

Similar Items